Chest
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rickles, F. R.
Right arrow Articles by Fernandez, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rickles, F. R.
Right arrow Articles by Fernandez, P. M.
(Chest. 2003;124:58S-68S.)
© 2003 American College of Chest Physicians

Tissue Factor, Thrombin, and Cancer*

Frederick R. Rickles, MD; Steven Patierno, PhD and Patricia M. Fernandez, PhD

* From the Departments of Medicine, Pediatrics, Pharmacology, and Urology, The George Washington University, Washington, DC.

Correspondence to: Frederick R. Rickles, MD, Executive Director, Federation of American Societies for Experimental Biology, 9650 Rockville Pike, Bethesda, MD 20814-3998

In addition to its primary role in hemostasis and blood coagulation, thrombin is a potent mitogen capable of inducing cellular functions. Therefore, it should come as no surprise that thrombin has proved to be of importance in the behavior of cancer. In this review, we focus on the ability of tissue factor (TF) and thrombin to influence tumor angiogenesis. Both exert their influence on angiogenesis through clotting-dependent and clotting-independent mechanisms: (1) directly affecting signaling pathways that mediate cell functions, and (2) mediating clot formation, thereby providing a growth media for tumor cells. Therefore, anticoagulant drugs may prove efficacious in cancer treatment due to their ability to reduce the characteristic hypercoagulability of cancer and alter the fundamental biology of cancer.

Key Words: angiogenesis • cancer • fibrinogen • thrombosis • tissue factor




This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
M. Adess, R. Eisner, S. Nand, J. Godwin, H. L. Messmore Jr, and W. H. Wehrmacher
Thromboembolism in Cancer Patients: Pathogenesis and Treatment
Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 254 - 266.
[Abstract] [PDF]

Home page
 JCOHome page
A. A. Khorana, C. W. Francis, E. Culakova, R. I. Fisher, N. M. Kuderer, and G. H. Lyman
Thromboembolism in Hospitalized Neutropenic Cancer Patients
J. Clin. Oncol., January 20, 2006; 24(3): 484 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Belting, J. Ahamed, and W. Ruf
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1545 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Y.Y. Lee, F. R. Rickles, J. A. Julian, M. Gent, R. I. Baker, C. Bowden, A. K. Kakkar, M. Prins, and M. N. Levine
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism
J. Clin. Oncol., April 1, 2005; 23(10): 2123 - 2129.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman
Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1015 - 1022.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.